Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for CRISPR Therapeutics (CRSP): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
29 analysts
Options Flow (P/C)
0.52
More calls — Bullish
Avg Consensus PT
$72
+32.9%
Highest Price Target
$120
+120.8%
Lowest Price Target
$32
-41.1%
Short Interest
22.6%
Rising — Bearish
Insider Activity (30d)
Neutral
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Citizens | Silvan Turkcan— | +47.2% | $80 → $80 | Maintained | Market Outperform |
| Aug 31, 2026 | Needham | Gil Blum— | +50.9% | $82 → $82 | Maintained | Buy |